RaySearch Laboratories AB (publ)
OTC: RSLBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Johan Lof
- Employees
- 416
- Headquarters
- Stockholm, Sweden
- IPO year
- 2015
- Market cap
- $719.9M
- Website
- https://www.raysearchlabs.com
Loading RSLBF…
Loading profile data…Frequently asked questions about RSLBF
What does RaySearch Laboratories AB (publ) (RSLBF) do?
RaySearch Laboratories AB (publ) is a global medical technology innovator, dedicated to developing advanced software solutions for cancer treatment. Its flagship product, RayStation, serves as a comprehensive treatment planning platform, integrating sophisticated features such as automated planning, adaptive therapy, multi-criteria optimization,...
Where does RSLBF trade?
RaySearch Laboratories AB (publ) (RSLBF) trades on the Other OTC.
What sector is RSLBF in?
RaySearch Laboratories AB (publ) (RSLBF) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of RaySearch Laboratories AB (publ)?
Johan Lof is the chief executive officer of RaySearch Laboratories AB (publ) (RSLBF).
Where is RaySearch Laboratories AB (publ) headquartered?
RaySearch Laboratories AB (publ) is headquartered in Sweden.
Does RSLBF pay a dividend?
Yes — RaySearch Laboratories AB (publ) (RSLBF) paid a trailing twelve-month dividend of USD 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did RSLBF go public?
RaySearch Laboratories AB (publ) (RSLBF) completed its initial public offering in 2015.